Live Quote · NASDAQSTROHealthcare· Biotechnology

Sutro Biopharma, Inc.

$30.43 0.63%(+$0.19)
TickerSpark Score
70/100
Solid
67
Valuation
60
Profitability
95
Growth
68
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STRO research report →

52-Week Range63% of range
Low
$7.15
Current
$30.43
High
$43.85
Company Overviewwww.sutrobio.com

About the company

Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-based treatments for challenging conditions like cancer and autoimmune disorders.

CEO
Jane Chung
IPO
2018
Employees
269
HQ
South San Francisco, CA, US

Price Chart

+298.30% · this period
$40.91$24.10$7.30Jul 02Dec 31Jul 02
Valuation
Market Cap
$294.48M
P/E
-0.10
P/S
2.96
P/B
-0.06
EV/EBITDA
-2.21
Div Yield
0.00%
Profitability
Gross Margin
98.72%
Op Margin
-115.53%
Net Margin
-154.21%
ROE
192.77%
ROIC
-64.32%
Growth & Income
Revenue
$102.48M · 65.18%
Net Income
$-191,086,000 · 15.99%
EPS
$-22.49 · 24.02%
Op Income
$-104,952,000
FCF YoY
8.07%
Performance & Tape
52W High
$43.85
52W Low
$7.15
50D MA
$32.03
200D MA
$19.00
Beta
1.55
Avg Volume
340.53K

Get TickerSpark's AI analysis on STRO

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 5, 26Wigginton Jon Marcother10,000
Jun 5, 26Petree Daniel Hother10,000
Jun 5, 26PANEK JAMES Pother10,000
Jun 5, 26Lobacki Joseph Mother10,000
Jun 5, 26Jagpal Sukhiother10,000
Jun 5, 26Hunter Heidiother10,000
Jun 5, 26Dybbs Michaelother10,000
Jun 5, 26MATSUI CONNIEother10,000
Jun 2, 26Chow Gregory K.other2,500
Jun 2, 26Chow Gregory K.other2,500
Coverage · STRO

Our STRO coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on STRO yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate STRO report →
Internal Compare

Similar companies

Peers in the same neighborhood.